Impact of microvascular invasion on 5-year overall survival of resected non-small cell lung cancer

Detalhes bibliográficos
Autor(a) principal: Monteiro,Andreia Salarini
Data de Publicação: 2022
Outros Autores: Araújo,Sérgio Ricardo de Carvalho, Araujo,Luiz Henrique, Souza,Mirian Carvalho de
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Jornal Brasileiro de Pneumologia (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132022000300205
Resumo: ABSTRACT Objectives: Non-small cell lung cancer (NSCLC) is an incidental and aggressive type of cancer. Although curative treatment can be offered, the recurrence rate is relatively high. Identifying factors that have a prognostic impact may guide changes in the staging system and recommendations for adjuvant therapy. The aim of this study was to evaluate the impact of microvascular invasion on the 5-year overall survival (OS) of patients with resected NSCLC treated at a reference cancer center. Methods: This retrospective, observational cohort study included patients diagnosed with early-stage NSCLC (clinical stages I-IIIA), treated with curative-intent surgery at the Brazilian National Cancer Institute between 2010 and 2016. Results: The dataset comprised 91 surgical patients, mostly females and white, with a mean age of 62 years (range between 29-83). Cases were distributed as stages I, II, and III in 55%, 29%, and 16%. Adenocarcinoma was the predominant histological subtype (67%), and microvascular invasion was present in 25% of the patients. The 5-year OS probability was 60% (95% CI, 48.3-68.9). Among all characteristics, advanced stages (p = 0.001) and the presence of microvascular invasion (p< 0.001) were related to a worse 5-year OS. After adjusting for age group and pathological stage, the presence of microvascular invasion was associated with a 4-fold increased risk of death (HR 3.9, 95% CI, 1.9-8.2). Conclusion: The presence of microvascular invasion was an independent factor related to worse survival and, therefore, should be routinely assessed in resected specimens.
id SBPT-1_16482b05446a4671a912577a49193fbc
oai_identifier_str oai:scielo:S1806-37132022000300205
network_acronym_str SBPT-1
network_name_str Jornal Brasileiro de Pneumologia (Online)
repository_id_str
spelling Impact of microvascular invasion on 5-year overall survival of resected non-small cell lung cancernon-small cell lung cancerthoracic surgerysurvival analysismicrovascular invasion.ABSTRACT Objectives: Non-small cell lung cancer (NSCLC) is an incidental and aggressive type of cancer. Although curative treatment can be offered, the recurrence rate is relatively high. Identifying factors that have a prognostic impact may guide changes in the staging system and recommendations for adjuvant therapy. The aim of this study was to evaluate the impact of microvascular invasion on the 5-year overall survival (OS) of patients with resected NSCLC treated at a reference cancer center. Methods: This retrospective, observational cohort study included patients diagnosed with early-stage NSCLC (clinical stages I-IIIA), treated with curative-intent surgery at the Brazilian National Cancer Institute between 2010 and 2016. Results: The dataset comprised 91 surgical patients, mostly females and white, with a mean age of 62 years (range between 29-83). Cases were distributed as stages I, II, and III in 55%, 29%, and 16%. Adenocarcinoma was the predominant histological subtype (67%), and microvascular invasion was present in 25% of the patients. The 5-year OS probability was 60% (95% CI, 48.3-68.9). Among all characteristics, advanced stages (p = 0.001) and the presence of microvascular invasion (p< 0.001) were related to a worse 5-year OS. After adjusting for age group and pathological stage, the presence of microvascular invasion was associated with a 4-fold increased risk of death (HR 3.9, 95% CI, 1.9-8.2). Conclusion: The presence of microvascular invasion was an independent factor related to worse survival and, therefore, should be routinely assessed in resected specimens.Sociedade Brasileira de Pneumologia e Tisiologia2022-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132022000300205Jornal Brasileiro de Pneumologia v.48 n.3 2022reponame:Jornal Brasileiro de Pneumologia (Online)instname:Sociedade Brasileira de Pneumologia e Tisiologia (SBPT)instacron:SBPT10.36416/1806-3756/e20210283info:eu-repo/semantics/openAccessMonteiro,Andreia SalariniAraújo,Sérgio Ricardo de CarvalhoAraujo,Luiz HenriqueSouza,Mirian Carvalho deeng2022-07-06T00:00:00Zoai:scielo:S1806-37132022000300205Revistahttp://www.jornaldepneumologia.com.br/default.aspONGhttps://old.scielo.br/oai/scielo-oai.php||jbp@jbp.org.br|| jpneumo@jornaldepneumologia.com.br1806-37561806-3713opendoar:2022-07-06T00:00Jornal Brasileiro de Pneumologia (Online) - Sociedade Brasileira de Pneumologia e Tisiologia (SBPT)false
dc.title.none.fl_str_mv Impact of microvascular invasion on 5-year overall survival of resected non-small cell lung cancer
title Impact of microvascular invasion on 5-year overall survival of resected non-small cell lung cancer
spellingShingle Impact of microvascular invasion on 5-year overall survival of resected non-small cell lung cancer
Monteiro,Andreia Salarini
non-small cell lung cancer
thoracic surgery
survival analysis
microvascular invasion.
title_short Impact of microvascular invasion on 5-year overall survival of resected non-small cell lung cancer
title_full Impact of microvascular invasion on 5-year overall survival of resected non-small cell lung cancer
title_fullStr Impact of microvascular invasion on 5-year overall survival of resected non-small cell lung cancer
title_full_unstemmed Impact of microvascular invasion on 5-year overall survival of resected non-small cell lung cancer
title_sort Impact of microvascular invasion on 5-year overall survival of resected non-small cell lung cancer
author Monteiro,Andreia Salarini
author_facet Monteiro,Andreia Salarini
Araújo,Sérgio Ricardo de Carvalho
Araujo,Luiz Henrique
Souza,Mirian Carvalho de
author_role author
author2 Araújo,Sérgio Ricardo de Carvalho
Araujo,Luiz Henrique
Souza,Mirian Carvalho de
author2_role author
author
author
dc.contributor.author.fl_str_mv Monteiro,Andreia Salarini
Araújo,Sérgio Ricardo de Carvalho
Araujo,Luiz Henrique
Souza,Mirian Carvalho de
dc.subject.por.fl_str_mv non-small cell lung cancer
thoracic surgery
survival analysis
microvascular invasion.
topic non-small cell lung cancer
thoracic surgery
survival analysis
microvascular invasion.
description ABSTRACT Objectives: Non-small cell lung cancer (NSCLC) is an incidental and aggressive type of cancer. Although curative treatment can be offered, the recurrence rate is relatively high. Identifying factors that have a prognostic impact may guide changes in the staging system and recommendations for adjuvant therapy. The aim of this study was to evaluate the impact of microvascular invasion on the 5-year overall survival (OS) of patients with resected NSCLC treated at a reference cancer center. Methods: This retrospective, observational cohort study included patients diagnosed with early-stage NSCLC (clinical stages I-IIIA), treated with curative-intent surgery at the Brazilian National Cancer Institute between 2010 and 2016. Results: The dataset comprised 91 surgical patients, mostly females and white, with a mean age of 62 years (range between 29-83). Cases were distributed as stages I, II, and III in 55%, 29%, and 16%. Adenocarcinoma was the predominant histological subtype (67%), and microvascular invasion was present in 25% of the patients. The 5-year OS probability was 60% (95% CI, 48.3-68.9). Among all characteristics, advanced stages (p = 0.001) and the presence of microvascular invasion (p< 0.001) were related to a worse 5-year OS. After adjusting for age group and pathological stage, the presence of microvascular invasion was associated with a 4-fold increased risk of death (HR 3.9, 95% CI, 1.9-8.2). Conclusion: The presence of microvascular invasion was an independent factor related to worse survival and, therefore, should be routinely assessed in resected specimens.
publishDate 2022
dc.date.none.fl_str_mv 2022-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132022000300205
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132022000300205
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.36416/1806-3756/e20210283
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Pneumologia e Tisiologia
publisher.none.fl_str_mv Sociedade Brasileira de Pneumologia e Tisiologia
dc.source.none.fl_str_mv Jornal Brasileiro de Pneumologia v.48 n.3 2022
reponame:Jornal Brasileiro de Pneumologia (Online)
instname:Sociedade Brasileira de Pneumologia e Tisiologia (SBPT)
instacron:SBPT
instname_str Sociedade Brasileira de Pneumologia e Tisiologia (SBPT)
instacron_str SBPT
institution SBPT
reponame_str Jornal Brasileiro de Pneumologia (Online)
collection Jornal Brasileiro de Pneumologia (Online)
repository.name.fl_str_mv Jornal Brasileiro de Pneumologia (Online) - Sociedade Brasileira de Pneumologia e Tisiologia (SBPT)
repository.mail.fl_str_mv ||jbp@jbp.org.br|| jpneumo@jornaldepneumologia.com.br
_version_ 1750318348275548160